                         SEQUENCE LISTING

<110>  Deutsches Krebsforschungszentrum Stiftung des ffentlichen 
       Rechts
 
<120>  Gpr177 as target and marker in tumors

<130>  50141 PEP

<140>  EP11162877.2
<141>  2011-04-18

<160>  20    

<170>  PatentIn version 3.5

<210>  1
<211>  16
<212>  PRT
<213>  Homo sapiens

<400>  1

Phe Thr Ser Pro Lys Thr Pro Glu His Glu Gly Arg Tyr Tyr Asn Cys 
1               5                   10                  15      


<210>  2
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Evi#1

<400>  2
acgaaucccu ucuacagua                                                    19


<210>  3
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Evi#2

<400>  3
uaacggaagg ccauuggaa                                                    19


<210>  4
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Evi#3

<400>  4
uaaaggauau ccgguugguu                                                   20


<210>  5
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Control siRNA

<400>  5
gcugaaacau gcaguugua                                                    19


<210>  6
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Control siRNA

<400>  6
gauaaaggcu acuguugga                                                    19


<210>  7
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Control siRNA

<400>  7
ccacuaaugu ccagcguuu                                                    19


<210>  8
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  siRNA against beta-catenin

<400>  8
acaaguagcu gauauugau                                                    19


<210>  9
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer Evi/Gpt177

<400>  9
tcatggtatt tcaggtgttt cg                                                22


<210>  10
<211>  23
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  probe#38, Roche

<400>  10
gcatgaggaa cttgaaccta aaa                                               23


<210>  11
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  beta-Catenin

<400>  11
agctagacca gctctctctt ca                                                22


<210>  12
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  probe #21, Roche

<400>  12
caatatcaag tccaagatca gc                                                22


<210>  13
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Cyclin DI

<400>  13
gaagatcgtc gccacctg                                                     18


<210>  14
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  probe #67, Roche

<400>  14
gacctcctcc tcgcacttct                                                   20


<210>  15
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  c-Myc

<400>  15
caccagcagc gactctga                                                     18


<210>  16
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  probe #34, Roche

<400>  16
gatccagact ctgacctttt gc                                                22


<210>  17
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  PTMA

<400>  17
cctgctaacg gggaatgtaa                                                   20


<210>  18
<211>  23
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  probe #75, Roche

<400>  18
cttcctcttc ttcgtctacc tca                                               23


<210>  19
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  IL-8

<400>  19
atggttcctt ccggtggt                                                     18


<210>  20
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  probe #72, Roche

<400>  20
agacagcaga gcacacaagc                                                   20


